Viewing data from:

FEXOFENADINE HYDROCHLORIDE ALLERGY

ANDA

FEXOFENADINE HYDROCHLORIDE | A204507 | SCIEGEN PHARMACEUTICALS INC

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 10 NDCs

Highest NADAC/Unit

$0.2445

per ea

Lowest NADAC/Unit

$0.1562

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00904748602FEXOFENADINE HCL 180 MG TABLET	$0.2445	EA	Generic	—	2026-06-17
00904748640FEXOFENADINE HCL 180 MG TABLET	$0.2445	EA	Generic	—	2026-06-17
00904748660FEXOFENADINE HCL 180 MG TABLET	$0.2445	EA	Generic	—	2026-06-17
00904705040FEXOFENADINE HCL 180 MG TABLET	$0.2445	EA	Generic	—	2026-06-17
00904705060FEXOFENADINE HCL 180 MG TABLET	$0.2445	EA	Generic	—	2026-06-17
00904719240FEXOFENADINE HCL 60 MG TABLET	$0.1562	EA	Generic	—	2026-06-17

Showing 6 of 10 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 6 NDCs (6 FSS)

Lowest Price

$4.69

Highest Price

$74.12

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00904-7486-02FEXOFENADINE HCL 180MG TAB	$4.69	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-7486-40FEXOFENADINE HCL 180MG TAB	$74.12	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-7486-60FEXOFENADINE HCL 180MG TAB	$12.20	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-7192-04FEXOFENADINE HCL 60MG TAB	$10.50	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-7192-40FEXOFENADINE HCL 60MG TAB	$64.28	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030
00904-7192-60FEXOFENADINE HCL 60MG TAB	$12.59	FSS	The Harvard Drug Group L.L.C. dba Major Pharmaceuticals and Rugby Labs	05/31/2030

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain16 active DMFs8 inactive

14 active API suppliers hold Drug Master Files for this ingredient.

DR REDDYS LABORATORIES LTDFEXOFENADINE HYDROCHLORIDE

DMF 157572001

WOCKHARDT LTDFEXOFENADINE HYDROCHLORIDE

DMF 198162006

MATRIX PHARMACORP PRIVATE LTDFEXOFENADINE HYDROCHLORIDE USP

DMF 223682008

SYNTHIMED LABS PRIVATE LTDFEXOFENADINE HYDROCHLORIDE USP

DMF 245972011

HETERO DRUGS LTDFEXOFENADINE HYDROCHLORIDE

DMF 256372011

JUBILANT BIOSYS LTDFEXOFENADINE HYDROCHLORIDE

DMF 267182013

DIPHARMA FRANCIS SRLFEXOFENADINE HYDROCHLORIDE USP FORM A

DMF 282872014

DIPHARMA FRANCIS SRLFEXOFENADINE HYDROCHLORIDE USP FORM l

DMF 286122014

APITORIA PHARMA PRIVATE LTDFEXOFENADINE HYDROCHLORIDE USP

DMF 289952015

PERRIGO API LTDFEXOFENADINE HYDROCHLORIDE

DMF 294452015

VASUDHA PHARMA CHEM LTDFEXOFENADINE HYDROCHLORIDE USP

DMF 297402015

GRANULES INDIA LTDFEXOFENADINE HYDROCHLORIDE, USP

DMF 306042016

MOREPEN LABORATORIES LTDFEXOFENADINE HYDROCHLORIDE USP

DMF 306922016

DR REDDYS LABORATORIES LTDFEXOFENADINE HYDROCHLORIDE USP (FORM-I)

DMF 346452020

THINQ PHARMA-CRO LTDFEXOFENADINE HYDROCHLORIDE USP

DMF 362552021

CHEMECA DRUGS PRIVATE LTDFEXOFENADINE HYDROCHLORIDE USP

DMF 365542021

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveFEXOFENADINE HYDROCHLORIDE USP

DMF 154192001

FARMHISPANIA SAInactiveFEXOFENADINE HYDROCHLORIDE

DMF 155212001

WOCKHARDT LTDInactiveFEXOFENADINE HYDROCHLORIDE

DMF 159772002

DIPHARMA FRANCIS SRLInactiveFEXOFENADINE HYDROCHLORIDE USP

DMF 160292002

CIPLA LTDInactiveFEXOFENADINE HYDROCHLORIDE USP

DMF 188002005

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveFEXOFENADINE HYDROCHLORIDE

DMF 189492005

SANOFI AVENTIS DEUTSCHLAND GMBHInactiveFEXOFENADINE HYDROCHLORIDE (MDL 16455 A)

DMF 233602009

RA CHEM PHARMA LTDInactiveFEXOFENADINE HYDROCHLORIDE USP

DMF 297352015

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#002 — 60MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Sep 16, 2015

No patent or exclusivity listings for this strength.

#003 — 180MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 16, 2015

#004 — 60MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 16, 2015

#005 — 180MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 16, 2015